By Colleen Murphy | February 8, 2023
"It is probably one of the most significant decisions on arbitrations released by that court in many years," said former state Supreme Court Justice Peter G. Verniero of Wednesday's ruling. "Practitioners will need to review the decision carefully to anticipate its impact in this area of law."
By Colleen Murphy | February 2, 2023
"Legal duties do not spring from silence. Congress never said that drug makers must deliver discounted Section 340B drugs to an unlimited number of contract pharmacies," Judge Stephanos Bibas wrote. "So by trying to enforce that supposed requirement, the government overstepped the statute's bounds. And HHS did not violate the APA by purporting to withdraw the proposed ADR Rule before later finalizing it."
By Amanda Bronstad | February 1, 2023
Plaintiffs lawyers prepped for talc trials soon after Monday's decision by the Third Circuit dismissing the J&J bankruptcy, but they might have to wait a bit longer.
By Colleen Murphy | January 30, 2023
"The inflated co-pays are key to the alleged scheme because the higher amounts essentially force patients into the program," Judge John Michael Vazquez wrote. "The second part of the purported SaveOnSP Program is to target patients. Plaintiff alleges that defendant uses the threat of the artificially inflated copay to coerce patients into enrolling in the SaveOnSP Program."
By Colleen Murphy | January 20, 2023
"Applying the AOM statute as enacted, we conclude the judge erred in rejecting the sworn statement plaintiffs submitted pursuant to N.J.S.A. 2A:53A-28 and in dismissing the complaint with prejudice," the per curiam opinion stated. "On remand, we direct the matter be assigned to a different judge."
New Jersey Law Journal | Commentary
By Law Journal Editorial Board | December 30, 2022
S-3343 is of questionable constitutionality and necessity.
By Amanda Bronstad | December 22, 2022
Judges in high-profile mass tort bankruptcies involving Johnson & Johnson's talcum powder and 3M's combat earplugs came out with critical rulings this year, but all eyes are on appeals for 2023.
By Amanda Bronstad | December 20, 2022
Ken Feinberg told a bankruptcy judge on Tuesday that he was "under the gun" to complete a report that estimated the total value and volume of cancer claims over Johnson & Johnson's baby powder.
By Amanda Bronstad | December 19, 2022
In a Dec. 16 complaint, Johnson & Johnson subsidiary LTL Management claimed Dr. Jacqueline Moline falsified a 2019 article on which plaintiffs lawyers relied in cases linking mesothelioma to its baby powder.
By Charles Toutant | December 12, 2022
"As the ruling greatly simplifies the calculation of damages due to the class here, we look forward to completing discovery and trial in the near future," said Christopher Placitella, lead counsel for the class in the suit against Springpoint Senior Living.
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
McManimon, Scotland & Baumann, LLC is seeking talented and motivated associate attorneys for several positions. Candidates must be admi...
Lower Manhattan firm seeks a litigator with at least 2-4 years of experience in all aspects of commercial litigation (i.e., depositions and ...
A prestigious matrimonial law firm in Garden City is seeking a skilled Associate Attorney with 5 to 7 years of experience in family law. The...